Pages that link to "Q72837038"
Jump to navigation
Jump to search
The following pages link to AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes (Q72837038):
Displaying 39 items.
- Tissue-specific MR contrast agents (Q30778784) (← links)
- Current state of imaging for lung cancer staging (Q30961475) (← links)
- Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON) (Q31153181) (← links)
- Magnetic resonance imaging of the prostate (Q33769949) (← links)
- Delivery of diagnostic agents for magnetic resonance imaging (Q33933435) (← links)
- MRI of the female and male pelvis: current and future applications of contrast enhancement (Q33991728) (← links)
- Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma (Q35112643) (← links)
- Histological study of the biodynamics of iron oxide nanoparticles with different diameters (Q35153715) (← links)
- High-field small animal magnetic resonance oncology studies. (Q35312455) (← links)
- Newer MR imaging techniques for head and neck (Q35652077) (← links)
- Imaging the lymphatic system: possibilities and clinical applications (Q35685176) (← links)
- Magnetic resonance molecular imaging with nanoparticles (Q35980840) (← links)
- Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI. (Q36223384) (← links)
- Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI. (Q36284983) (← links)
- 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. (Q36336344) (← links)
- Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging (Q36471084) (← links)
- Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells (Q36765037) (← links)
- Preparation and evaluation of poly(2-hydroxyethyl aspartamide)-hexadecylamine-iron oxide for MR imaging of lymph nodes (Q37597552) (← links)
- Nanoimaging and neurological surgery (Q37776462) (← links)
- Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findings (Q39343765) (← links)
- Longitudinal 3.0T MRI analysis of changes in lymph node volume and apparent diffusion coefficient in an experimental animal model of metastatic and hyperplastic lymph nodes (Q39555272) (← links)
- Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues (Q41376679) (← links)
- Preoperative and postoperative imaging for colorectal cancer (Q41563180) (← links)
- Magnetic resonance imaging of cells in experimental disease models (Q42726387) (← links)
- Lymphoma: a clinical view (Q42926735) (← links)
- Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration (Q44394289) (← links)
- Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability (Q45739358) (← links)
- Use of USPIO-induced magnetic susceptibility artifacts to identify sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous Combidex dose in rats (Q47277320) (← links)
- Interstitial MR and CT lymphography with Gd-dTPA-co-alpha, omega-diaminoPEG(1450) and Gd-dTPA-co-1,6-diaminohexane polymers: preliminary experience. (Q53655205) (← links)
- Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis (Q59340216) (← links)
- Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas (Q86301436) (← links)
- Axillary lymph node metastases: A statistical analysis of various parameters in MRI with USPIO (Q60499713) (← links)
- Preliminary clinical experience with AMI 227 (Q71510914) (← links)
- Contrast agent for magnetic resonance angiography: experimental evaluation of superparamagnetic iron oxide composed of polysaccharide complex involving chondroitinsulfuric acid (Q71510916) (← links)
- Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging (Q71510996) (← links)
- MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection (Q73120786) (← links)
- Small pelvic lymph node metastases: evaluation with MR imaging (Q73457404) (← links)
- The Influence of the Sample Preparation on Plasma Protein Adsorption Patterns on Polysaccharide-stabilized Iron Oxide Particles and N-terminal Microsequencing of Unknown Proteins (Q74386568) (← links)
- MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex) (Q74483542) (← links)